1. Postoperative pain control with ropivacaine following laparoscopic myomectomy: A randomized double‐blind, pilot study.
- Author
-
Kwack, Jae Young, Ahn, Kwang Hee, and Kwon, Yong‐Soon
- Subjects
POSTOPERATIVE pain prevention ,LAPAROSCOPIC surgery ,PAIN ,STATISTICAL sampling ,SURGICAL complications ,UTERINE fibroids ,PAIN management ,PILOT projects ,RANDOMIZED controlled trials ,BLIND experiment ,ROPIVACAINE ,THERAPEUTICS - Abstract
Aim: The aim of this study was to evaluate immediate pain control in patients who underwent laparoscopic myomectomy (LM) by intraoperative injection of ropivacaine into both uterosacral ligaments. Methods: The study was a prospective, double‐blind, randomized study. We analyzed 46 cases of LM performed between July 2015 and November 2016 by a single surgeon. We randomized the enrolled patients into either a ropivacaine or a saline injection group. Before the surgeon closed the abdominal wall, each 7.5% ropivacaine (5 mL) or saline (5 mL) was administered into both uterosacral ligaments through laparoscopic injection needle. We compared the pain intensity scores 2, 6, 12, and 24 h after injection between the two groups. Results: The pain intensity scores were not significantly different. However, the ropivacaine group requested less of the analgesic than the placebo‐injected group requested (P = 0.035). No patient in the ropivacaine group reported any side effects. Conclusion: Intraoperative ropivacaine injection into both uterosacral ligaments during LM can reduce the dosage of opioid analgesics. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF